Table 3.
Post-hoc t-tests and effect sizes for symptom changes from T1 to T2 and T1 to T3 for secondary outcomes: depressive, behaviour and physical symptoms
| T1–T2 | T1–T3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | M1 (SD) | M2 (SD) | t | d | n | M1 (SD) | M3 (SD) | t | d | |
| MFQ proxy | 19 | 13.32 (4.26) | 5.63 (4.52) | 8.52*** | 1.75 | 18 | 13.50 (4.30) | 6.17 (4.89) | 5.56*** | 1.59 |
| SDQ self | 18 | 13.72 (5.33) | 10.28 (6.54) | 1.86† | 0.58 | 17 | 14.00 (5.36) | 11.76 (7.26) | 1.05 | 0.35 |
| SDQ proxy | 18 | 16.67 (5.24) | 9.33 (5.17) | 7.26*** | 1.41 | 17 | 17.00 (5.20) | 9.94 (5.87) | 5.06*** | 1.27 |
| PHQ-15 | 16 | 9.06 (3.68) | 6.56 (4.24) | 2.60* | 0.63 | 15 | 8.87 (3.72) | 7.53 (5.83) | 0.97 | 0.27 |
T1 baseline, T2 post-intervention, T3 6-weeks follow-up, MFQ Mood and Feelings Questionnaire, SDQ Strengths and Difficulties Questionnaire, PHQ-15 Patient Health Questionnaire Physical Symptoms;
†p < .1; *p < .05; ***p < .001